NCT04084288

Brief Summary

The majority of patients undergoing total knee replacement(TKR) rely on opioids for postoperative analgesia. These medications have undesirable side effects and potential for abuse and addiction. The aim of this cohort study is to determine the incidence rate of patients who are able to maintain a low dose opioid regimen after TKR with the use of a multimodal approach that includes intraoperative auricular acupuncture protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 21, 2019

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 9, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 10, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2020

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

May 5, 2022

Completed
Last Updated

December 27, 2024

Status Verified

September 1, 2024

Enrollment Period

1.1 years

First QC Date

September 9, 2019

Results QC Date

March 16, 2021

Last Update Submit

December 23, 2024

Conditions

Keywords

Acupuncture, Total Knee Replacement

Outcome Measures

Primary Outcomes (1)

  • Low-dose Opioid Regimen Adherence

    The number of patients who maintain a low-dose opioid regimen (15 pills or less of 5mg oxycodone or 112.5 OME \[oral morphine equivalents\]) from postoperative day (POD) 0 to POD 30 throughout their Total Knee Replacement.

    postoperative day 0 to postoperative day 30

Secondary Outcomes (7)

  • Total Opioid Consumption

    post anesthesia care unit (PACU), postoperative day (POD) 1, POD7, POD14, POD30

  • Numerical Rating Scale (NRS) Pain Scores at Rest and With Movement

    post anesthesia care unit (PACU), postoperative day (POD) 1, POD7, POD14, POD30

  • Duration of Neuraxial Anesthesia in Hours

    postoperative day 1

  • Deviation From Prescribed Oral Pain Regimen

    Postoperative day 30

  • Number of Participants With Side Effects on POD1 and During the PACU Stay

    PACU, Postoperative day 1

  • +2 more secondary outcomes

Study Arms (1)

Postoperative Acupuncture

EXPERIMENTAL

Neuraxial anesthesia (spinal or combined spinal epidural (CSE) with up to 4cc mepivacaine 1.5%) and 2 blocks for postoperative pain (IPACK and adductor canal peripheral nerve blocks). Sedation will be provided. Tranexemic acid (TXA) will be dosed per surgeon request. A certified medical acupuncturist will perform ipsilateral Auricular Trauma Protocol (ATP) acupuncture at eight ear points (Hypothalamus, Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Shen Men, Insula, Vagus) with 30Hz electrostimulation at two of those points (Shen Men and Hypothalamus). Acupuncture needles will be left in place and stimulated for 60 min and then removed. If an epidural is placed, it may be redosed with lidocaine as needed (up to 100mg total) and will be removed prior to transfer to the recovery room. A periarticular injection (PAI) will be placed by the surgeon during the surgery (timing at the discretion of the surgeon)

Other: AcupunctureDevice: Peripheral Nerve Stimulator

Interventions

Ipsilateral Auricular Trauma Protocol (ATP) acupuncture at eight ear points (Hypothalamus, Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Shen Men, Insula, Vagus) with 30Hz electrostimulation at two of those points (Shen Men and Hypothalamus). Acupuncture needles will be left in place and stimulated for 60 min and then removed

Postoperative Acupuncture

Ipsilateral Auricular Trauma Protocol (ATP) acupuncture at eight ear points (Hypothalamus, Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Shen Men, Insula, Vagus) with 30Hz electrostimulation at two of those points (Shen Men and Hypothalamus).

Postoperative Acupuncture

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA of 1 or 2
  • Age 18-70
  • Undergoing primary total knee replacement
  • Desire to attempt a low opioid or opioid free pathway

You may not qualify if:

  • NonEnglish speaking
  • Patients with the inability to understand or follow study protocol
  • Opioid use in the last 6 weeks or chronic pain patient
  • Cannot receive neuraxial anesthesia and/or peripheral nerve block
  • Patients with contraindications to intraop protocol (e.g., patient cannot take acetaminophen or ketorolac due to liver or kidney disease)
  • Patients with implanted cardiac device such as a pacemaker or AICD
  • Active ear infection
  • Nonnative ear, previous scarring or surgical manipulation of ear
  • Patients with gauges or other deforming ear piercing (small nondeforming ear piercings are ok) present in ears
  • Allergy to nickel

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

Location

MeSH Terms

Conditions

Osteoarthritis, KneePain, Postoperative

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Results Point of Contact

Title
Dr. Stephanie Cheng
Organization
Hospital for Special Surgery

Study Officials

  • Stephanie Cheng, MD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2019

First Posted

September 10, 2019

Study Start

August 21, 2019

Primary Completion

October 2, 2020

Study Completion

October 2, 2020

Last Updated

December 27, 2024

Results First Posted

May 5, 2022

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Beginning 3 months and ending 5 years following article publication.
Access Criteria
Researchers who provide a methodologically sound proposal. This will be done to achieve aims in the approved proposal. Proposals should be directed to chengs@hss.edu. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years at a third party website.

Locations